The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis
Open accessAbstract
Allergic bronchopulmonary aspergillosis (ABPA) is a Th2 hypersensitivity lung disease in response to Aspergillus fumigatus that affects asthmatic and cystic fibrosis (CF) patients. Sensitization to A. fumigatus is common in both atopic asthmatic and CF patients, yet only 1-2% of asthmatic and 7–9% of CF patients develop ABPA. ABPA is characterized by wheezing and pulmonary infiltrates which may lead to pulmonary fibrosis and/or bronchiectasis. The inflammatory response is characterized by Th2 responses to Aspergillus allergens, increased serum IgE and eosinophilia. A number of genetic risks have recently been identified in the development of ABPA. These include HLA-DR and HLA-DQ, IL-4 receptor alpha chain (IL-4RA) polymorphisms, IL-10-1082GA promoter polymorphisms, surfactant protein A2 (SP-A2) polymorphisms, and cystic fibrosis transmembrane conductance regulator gene (CFTR) mutations. The studies indicate that ABPA patients are genetically at risk to develop skewed and heightened Th2 responses to A. fumigatus antigens. These genetic risk studies and their consequences of elevated biologic markers may aid in identifying asthmatic and CF patients who are at risk to the development of ABPA. Furthermore, these studies suggest that immune modulation with medications such as anti-IgE, anti-IL-4 and/or IL-13 monoclonal antibodies may be helpful in the treatment of ABPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The IL-4 receptor: signaling mechanisms and biologic functions
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545 · cited 2×
“IL-4 receptor type II, also known as the IL13 receptor, is formed by the association of IL-4RA with the IL-13RA subunits and is located on immune cells, bronchial epithelium, and vascular endothelium.”
BackgroundStevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790
Self-citationAllergic Bronchopulmonary Aspergillosis: Staging as an Aid to Management
PATTERSON, R., GREENBERGER, P. A., RADIN, R. C., & ROBERTS, M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-3-286 · Cited by 327
O'Driscoll, B. R., Hopkinson, L. C., & Denning, D. W. (2005) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-5-4 · Cited by 254
IgE Sensitization to Aspergillus fumigatus Is Associated with Reduced Lung Function in Asthma
Fairs, A., Agbetile, J., Hargadon, B., Bourne, M., Monteiro, W. R., Brightling, C. E., Bradding, P., Green, R. H., Mutalithas, K., Desai, D., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0087oc · Cited by 252
The effect of outdoor fungal spore concentrations on daily asthma severity.
Delfino, R. J., Zeiger, R. S., Seltzer, J. M., Street, D. H., Matteucci, R. M., Anderson, P. R., & Koutrakis, P. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105622 · Cited by 191
Nelson, H. S., Szefler, S. J., Jacobs, J., Huss, K., Shapiro, G., & Sternberg, A. L. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70287-3 · Cited by 178
Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells
Paris, S., Boisvieux-Ulrich, E., Crestani, B., Houcine, O., Taramelli, D., Lombardi, L., & Latgé, J. P. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1510-1514.1997 · Cited by 149
Influence of Interleukin‐10 on Aspergillus fumigatus Infection in Patients with Cystic Fibrosis
Brouard, J., Knauer, N., Boelle, P., Corvol, H., Henrion‐Caude, A., Flamant, C., Bremont, F., Delaisi, B., Duhamel, J., Marguet, C., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429964 · Cited by 120
Reijmerink, N. E., Kerkhof, M., Koppelman, G. H., Gerritsen, J., De Jongste, J. C., Smit, H. A., Brunekreef, B., & Postma, D. S. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.01939.x · Cited by 54
Cited by
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Cystic fibrosis genetics: from molecular understanding to clinical application
Cutting, G. R. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3849 · Cited by 965
Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Saiman, L., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., Downer, V. S., Fliege, J., Hazle, L. A., Jain, M., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676882 · Cited by 387
Fungal allergy in asthma-state of the art and research needs
Denning, D. W., Pashley, C., Hartl, D., Wardlaw, A., Godet, C., Del Giacco, S., Delhaes, L., & Sergejeva, S. (2014) · Clinical and Translational Allergy · doi:10.1186/2045-7022-4-14 · Cited by 357
Corvol, H., Blackman, S. M., Boëlle, P.-Y., Gallins, P. J., Pace, R. G., Stonebraker, J. R., Accurso, F. J., Clement, A., Collaco, J. M., Dang, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9382 · Cited by 278
Metadata
- Authors
- Knutsen, A. P., & Slavin, R. G.
- Venue
- Clinical and Developmental Immunology
- Publisher
- Hindawi Limited
- Published
- 2011
- Volume
- 2011
- Pages
- 1-13
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- OpenAlex
- W2088624642
- Cited by
- 209
- References
- 10
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis. https://app.cochat.ai/papers/10.1155/2011/843763
- The paper
- Knutsen, A. P., & Slavin, R. G. (2011). Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis. Clinical and Developmental Immunology. https://doi.org/10.1155/2011/843763
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.